EDGAR Filing Documents for 0001047469-13-002403

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-13-002403

Filing Date

2013-03-08

Accepted

2013-03-08 12:53:01

Documents

Period of Report

2012-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a2213308z10-k.htm	10-K	1173593
2	EX-21	a2213308zex-21.htm	EX-21	3284
3	EX-23.1	a2213308zex-23_1.htm	EX-23.1	2851
4	EX-31.1	a2213308zex-31_1.htm	EX-31.1	8866
5	EX-31.2	a2213308zex-31_2.htm	EX-31.2	8873
6	EX-32	a2213308zex-32.htm	EX-32	7419
13	G610386.JPG	g610386.jpg	GRAPHIC	43566
	Complete submission text file	0001047469-13-002403.txt		8075595

Data Files

Seq	Description	Document	Type	Size
7	EX-101.INS	cldx-20121231.xml	EX-101.INS	934443
8	EX-101.SCH	cldx-20121231.xsd	EX-101.SCH	70625
9	EX-101.CAL	cldx-20121231_cal.xml	EX-101.CAL	101800
10	EX-101.LAB	cldx-20121231_lab.xml	EX-101.LAB	1145420
11	EX-101.PRE	cldx-20121231_pre.xml	EX-101.PRE	535263
12	EX-101.DEF	cldx-20121231_def.xml	EX-101.DEF	319256

Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725

Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771

Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)